Summary:
The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has seen multiple anti-SARS-CoV-2 antibodies being generated globally. It is difficult, however, to assemble a useful compendium of these biological properties if they are derived from experimental measurements performed at different sites under different experimental conditions. The Coronavirus Immunotherapeutic Consortium (COVIC) circumvents these issues by experimentally...
Link:
https://pubmed.ncbi.nlm.nih.gov/36763096/?utm_source=Other&utm_medium=rss&utm_campaign=journals&utm_content=101517697&fc=None&ff=20230215001918&v=2.17.9.post6+86293ac
From feeds:
📚BioDBS Bibliography »
Database (Oxford)
Tags:
Authors:
Jarjapu Mahita, Brendan Ha, Anais Gambiez, Sharon L Schendel, Haoyang Li, Kathryn M Hastie, S Moses Dennison, Kan Li, Natalia Kuzmina, Sivakumar Periasamy, Alexander Bukreyev, Jennifer E Munt, Mary Osei-Twum, Caroline Atyeo, James A Overton, Randi Vita, Hector Guzman-Orozco, Marcus Mendes, Mari Kojima, Peter J Halfmann, Yoshihiro Kawaoka, Galit Alter, Luc Gagnon, Ralph S Baric, Georgia D Tomaras, Tim Germann, Daniel Bedinger, Jason A Greenbaum, Erica Ollmann Saphire, Bjoern Peters
Date tagged:
02/15/2023, 00:19
Date published:
02/10/2023, 06:00